Detailed 'genetic landscape' of ovarian cancer revealed : Cancer Research UK

Note: nice 'plain english language' article

My Healthy Today: Menopause Study: Flaxseed doesn't reduce women's hot flashes

Dr. Mark Kris, a cancer specialist at Memorial Sloan-Kettering Cancer Center in New York, said the flaxseed results are disappointing
"There were so many testimonials that we thought flaxseed was going to work, but a testimonial is not a rigorous clinical trial result, and that's what our patients deserve," he said.
"Even natural products do have side effects," so it's important to test them in studies such as this one, he said.

My Healthy Today - Menopause Increasing daily calcium will not reduce the risk of fractures in later life

The authors conclude that while low levels of calcium intake (less than 700 mg per day) increase the risk of fractures and osteoporosis, there is no need to start increasing calcium intake above the amount. Increases did not further reduce the fracture and osteoporosis risk.

Drug advertising in The Lancet : The Lancet

Patient Advocate Foundation (PAF) Co-Pay Relief Patient Center - August 1, 2011 - U.S.

EXCITING CHANGES ARE TAKING PLACE IN THE CO-PAY RELIEF (CPR) PROGRAM!

Patient Advocate Foundation (PAF), a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases, is pleased to announce significant improvements to its Co-Pay Relief (CPR) Program beginning on August 1, 2011 that will allow more patients to be served through a new operational model and will provide enhanced service to both providers and patients. The program will also leverage state-of-the-art technology solutions to deliver a high degree of automation and efficiency to program users.

Please Click Here to View a Complete Overview of These New Program Enhancements.

Are You Eligible?
The Patient Advocate Foundation (PAF) Co-Pay Relief Program (CPR) currently assists insured patients who are financially and medically qualified and are being treated for breast, lung, lymphoma and cutaneous t-cell lymphoma, prostate, kidney, colon, pancreatic, head/neck cancers, malignant brain tumor, sarcoma, diabetes, multiple myeloma, myelodysplastic syndrome (and other pre-leukemia diseases), osteoporosis, pain, hepatitis C, rheumatoid arthritis, selected autoimmune disorders and CIA/CIN.